Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  JCO Precision Oncology

• Publication date

  2025-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/PO-25-00290PMID 40825166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations

  2025cited by this paper
• Pediatric metastatic extracranial high-grade glioma: A case report and literature review.

  2025cited by this paper
• Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A

  2023cited by this paper
• Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

  2023cited by this paper
• Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy

  2022cited by this paper
• Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features

  2021cited by this paper
• The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification

  2020cited by this paper
• Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data.

  2019cited by this paper
• CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

  2018cited by this paper
• Recent global trends in testicular cancer incidence and mortality

  2018cited by this paper
• Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report.

  2018cited by this paper
• Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2− advanced breast cancer

  2018cited by this paper
• Characteristics of Patients With Sertoli and Leydig Cell Testis Neoplasms From a National Population‐Based Registry

  2017cited by this paper
• Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.

  2017cited by this paper
• Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.

  2015cited by this paper
• Increased incidence of Leydig cell tumours of the testis in the era of improved imaging techniques

  2011cited by this paper

• Advances in non‐germ cell tumours of the testis: focus on new molecular developments in sex cord‐stromal tumours

  2025cites this paper